?>
WalkingHorse

🎢🎡 ...And she went down swingin'... 🎢🎡

N/A

WalkingHorse

Posting my cancer story so that I have a place to refer folks interested in my cancer backstory.

N/A

WalkingHorse

The 5-year survival outcomes analysis of EGFR-TKI or/and chemotherapy as initial adjuvant therapy for completely resected IIIA non-small cell lung cancer

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Exploring the impact of neutrophils on lung adenocarcinoma using Mendelian randomization and transcriptomic study

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Therapeutic patterns and outcomes in older patients (aged β‰₯ 65 years) with stage III inoperable non-small cell lung cancer (NSCLC): An investigational study from the SEER database

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Dietary pattern and odds of lung cancer: a large case-control study in Iran | BMC Nutrition

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Deciphering the intratumoral histologic heterogeneity of lung adenocarcinoma using radiomics

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Radiomic Analysis and Liquid Biopsy in Preoperative CT of NSCLC: An Explorative Experience

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Expert Consensus on the Multidisciplinary Management and Resectability of Locally Advanced Non-Small Cell Lung Cancer

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Pan-cancer multi-omics profiling of MS4A2 unveils its functional landscape in lung adenocarcinoma

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

The SUPE_R Trial: Posttreatment Surveillance with 18F-FDG PET/CT in Stage I to III Non–Small Cell Lung Cancer

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Patient-reported walking difficulty predicting the post-discharge overall function in patients with lung cancer undergoing minimally invasive surgery

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

RIT1M90I is a driver of lung adenocarcinoma tumorigenesis and resistance to targeted therapy

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Lobectomy Versus Sub-lobectomy for Clinical Stage IA (≀2 cm) Lung Squamous Cell Carcinoma with Tumour Spread through Air Spaces: A Multi-Centre Retrospective Study

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Co-occurrence of interstitial lung disease and pulmonary embolism as adverse events of adjuvant osimertinib treatment for EGFR mutant non-small cell lung cancer: a case report | BMC Pulmonary Medicine

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Unraveling the tumor-microenvironment through a radiogenomic-based multiomic approach to predict outcomes of immunotherapy in non-small cell lung cancer

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Awake videothoracoscopic anatomic lung resections for non-small cell lung cancer under thoracic paravertebral block: clinical experiences | BMC Surgery

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Pathological significance and therapeutic prospects of HCCS expression patterns in lung adenocarcinoma

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Leveraging Tubulin Isotype Structural Differences to Design Less Hematotoxic Ξ²5 Selective Covalent Inhibitors for NSCLC

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Functional Imaging of Changes in Lung Function Before and After Radiation Therapy of Lung Cancer

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

An in-depth exploration of four heterogeneity structure-based EGFR mutation subgroups in Chinese non-small cell lung cancer | BMC Pulmonary Medicine

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

First-line serplulimab plus chemotherapy in extensive-stage small-cell lung cancer: Updated results and biomarker analysis from the ASTRUM-005 randomized clinical trial

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Cabozantinib overcomes ROS1 L2086F NSCLC resistance to lorlatinib: A case report

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Canadian Perspectives Revisited: Consensus on the management of ALK-rearranged NSCLC

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🀍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.